866-997-4948(US-Canada Toll Free)

Global Live Attenuated Vaccines Market Professional Survey Report 2019

Published By :

QYResearch

Published Date : Oct 2019

Category :

Pharmaceutical

No. of Pages : 104 Pages

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

The global Live Attenuated Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Live Attenuated Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Live Attenuated Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Live Attenuated Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Live Attenuated Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Bacterial
Viral

Segment by Application
Hospitals
Clinics
Research Institutes
Others
Table of Contents

Executive Summary
1 Industry Overview of Live Attenuated Vaccines
1.1 Definition of Live Attenuated Vaccines
1.2 Live Attenuated Vaccines Segment by Type
1.2.1 Global Live Attenuated Vaccines Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Bacterial
1.2.3 Viral
1.3 Live Attenuated Vaccines Segment by Applications
1.3.1 Global Live Attenuated Vaccines Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Live Attenuated Vaccines Overall Market
1.4.1 Global Live Attenuated Vaccines Revenue (2014-2025)
1.4.2 Global Live Attenuated Vaccines Production (2014-2025)
1.4.3 North America Live Attenuated Vaccines Status and Prospect (2014-2025)
1.4.4 Europe Live Attenuated Vaccines Status and Prospect (2014-2025)
1.4.5 China Live Attenuated Vaccines Status and Prospect (2014-2025)
1.4.6 Japan Live Attenuated Vaccines Status and Prospect (2014-2025)
1.4.7 Southeast Asia Live Attenuated Vaccines Status and Prospect (2014-2025)
1.4.8 India Live Attenuated Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccines
2.3 Manufacturing Process Analysis of Live Attenuated Vaccines
2.4 Industry Chain Structure of Live Attenuated Vaccines

3 Development and Manufacturing Plants Analysis of Live Attenuated Vaccines
3.1 Capacity and Commercial Production Date
3.2 Global Live Attenuated Vaccines Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Live Attenuated Vaccines
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Live Attenuated Vaccines Production and Capacity Analysis
4.2 Live Attenuated Vaccines Revenue Analysis
4.3 Live Attenuated Vaccines Price Analysis
4.4 Market Concentration Degree

5 Live Attenuated Vaccines Regional Market Analysis
5.1 Live Attenuated Vaccines Production by Regions
5.1.1 Global Live Attenuated Vaccines Production by Regions
5.1.2 Global Live Attenuated Vaccines Revenue by Regions
5.2 Live Attenuated Vaccines Consumption by Regions
5.3 North America Live Attenuated Vaccines Market Analysis
5.3.1 North America Live Attenuated Vaccines Production
5.3.2 North America Live Attenuated Vaccines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Live Attenuated Vaccines Import and Export
5.4 Europe Live Attenuated Vaccines Market Analysis
5.4.1 Europe Live Attenuated Vaccines Production
5.4.2 Europe Live Attenuated Vaccines Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Live Attenuated Vaccines Import and Export
5.5 China Live Attenuated Vaccines Market Analysis
5.5.1 China Live Attenuated Vaccines Production
5.5.2 China Live Attenuated Vaccines Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Live Attenuated Vaccines Import and Export
5.6 Japan Live Attenuated Vaccines Market Analysis
5.6.1 Japan Live Attenuated Vaccines Production
5.6.2 Japan Live Attenuated Vaccines Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Live Attenuated Vaccines Import and Export
5.7 Southeast Asia Live Attenuated Vaccines Market Analysis
5.7.1 Southeast Asia Live Attenuated Vaccines Production
5.7.2 Southeast Asia Live Attenuated Vaccines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Live Attenuated Vaccines Import and Export
5.8 India Live Attenuated Vaccines Market Analysis
5.8.1 India Live Attenuated Vaccines Production
5.8.2 India Live Attenuated Vaccines Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Live Attenuated Vaccines Import and Export

6 Live Attenuated Vaccines Segment Market Analysis (by Type)
6.1 Global Live Attenuated Vaccines Production by Type
6.2 Global Live Attenuated Vaccines Revenue by Type
6.3 Live Attenuated Vaccines Price by Type

7 Live Attenuated Vaccines Segment Market Analysis (by Application)
7.1 Global Live Attenuated Vaccines Consumption by Application
7.2 Global Live Attenuated Vaccines Consumption Market Share by Application (2014-2019)

8 Live Attenuated Vaccines Major Manufacturers Analysis
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Live Attenuated Vaccines Production Sites and Area Served
8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
8.1.3 GlaxoSmithKline Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck
8.2.1 Merck Live Attenuated Vaccines Production Sites and Area Served
8.2.2 Merck Product Introduction, Application and Specification
8.2.3 Merck Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Pfizer
8.3.1 Pfizer Live Attenuated Vaccines Production Sites and Area Served
8.3.2 Pfizer Product Introduction, Application and Specification
8.3.3 Pfizer Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Astellas Pharma
8.4.1 Astellas Pharma Live Attenuated Vaccines Production Sites and Area Served
8.4.2 Astellas Pharma Product Introduction, Application and Specification
8.4.3 Astellas Pharma Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Live Attenuated Vaccines Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 CSL
8.6.1 CSL Live Attenuated Vaccines Production Sites and Area Served
8.6.2 CSL Product Introduction, Application and Specification
8.6.3 CSL Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi
8.7.1 Sanofi Live Attenuated Vaccines Production Sites and Area Served
8.7.2 Sanofi Product Introduction, Application and Specification
8.7.3 Sanofi Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Serum Institute Of India
8.8.1 Serum Institute Of India Live Attenuated Vaccines Production Sites and Area Served
8.8.2 Serum Institute Of India Product Introduction, Application and Specification
8.8.3 Serum Institute Of India Live Attenuated Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Live Attenuated Vaccines Market
9.1 Global Live Attenuated Vaccines Market Trend Analysis
9.1.1 Global Live Attenuated Vaccines Market Size (Volume and Value) Forecast 2019-2025
9.2 Live Attenuated Vaccines Regional Market Trend
9.2.1 North America Live Attenuated Vaccines Forecast 2019-2025
9.2.2 Europe Live Attenuated Vaccines Forecast 2019-2025
9.2.3 China Live Attenuated Vaccines Forecast 2019-2025
9.2.4 Japan Live Attenuated Vaccines Forecast 2019-2025
9.2.5 Southeast Asia Live Attenuated Vaccines Forecast 2019-2025
9.2.6 India Live Attenuated Vaccines Forecast 2019-2025
9.3 Live Attenuated Vaccines Market Trend (Product Type)
9.4 Live Attenuated Vaccines Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Live Attenuated Vaccines Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table

List of Tables and Figures
Figure Picture of Live Attenuated Vaccines
Table Global Live Attenuated Vaccines Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Live Attenuated Vaccines Production Market Share by Types in 2018
Figure Bacterial Product Picture
Figure Viral Product Picture
Table Global Live Attenuated Vaccines Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Live Attenuated Vaccines Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Research Institutes
Figure Others
Figure Global Live Attenuated Vaccines Revenue (Million USD) (2014-2025)
Figure Global Live Attenuated Vaccines Production (K Units) (2014-2025)
Figure North America Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Figure Europe Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Figure China Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Figure Japan Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Figure Southeast Asia Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Figure India Live Attenuated Vaccines Market Size (Million USD) (2014-2025)
Table Live Attenuated Vaccines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Live Attenuated Vaccines in 2018
Figure Manufacturing Process Analysis of Live Attenuated Vaccines
Figure Industry Chain Structure of Live Attenuated Vaccines
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Live Attenuated Vaccines Manufacturing Plants Distribution
Table Live Attenuated Vaccines Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Live Attenuated Vaccines Capacity (K Units) of Major Manufacturers (2014-2019)
Table Live Attenuated Vaccines Production (K Units) of Major Manufacturers (2014-2019)
Table Live Attenuated Vaccines Production Market Share of Major Manufacturers (2014-2019)
Figure Live Attenuated Vaccines Production Share by Manufacturers in 2018
Table Live Attenuated Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Live Attenuated Vaccines Revenue Market Share of Major Manufacturers (2014-2019)
Figure Live Attenuated Vaccines Revenue Share by Manufacturers in 2018
Table Live Attenuated Vaccines Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Live Attenuated Vaccines Production by Regions 2014-2019 (K Units)
Table Global Live Attenuated Vaccines Production Market Share by Regions 2014-2019
Figure Global Live Attenuated Vaccines Production Market Share by Regions in 2018
Table Global Live Attenuated Vaccines Revenue by Regions 2014-2019 (Million USD)
Table Global Live Attenuated Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Live Attenuated Vaccines Revenue Market Share by Regions in 2018
Table Global Live Attenuated Vaccines Consumption by Regions 2014-2019 (K Units)
Table Global Live Attenuated Vaccines Consumption Market Share by Regions 2014-2019
Figure North America Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure North America Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table North America Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure Europe Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Europe Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure China Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure China Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table China Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure Japan Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Japan Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure Southeast Asia Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure India Live Attenuated Vaccines Production Growth Rate 2014-2019 (K Units)
Figure India Live Attenuated Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table India Live Attenuated Vaccines Production, Consumption Import and Export (K Units)
Figure Global Consumption Live Attenuated Vaccines Market Share by Application (2014-2019)
Figure Global Value (Consumption) Live Attenuated Vaccines Market Share by Application (2014-2019)
Table GlaxoSmithKline Live Attenuated Vaccines Production Sites and Area Served
Table GlaxoSmithKline Live Attenuated Vaccines Product Introduction, Application and Specification
Table GlaxoSmithKline Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table GlaxoSmithKline Live Attenuated Vaccines Production Market Share (2014-2019)
Figure GlaxoSmithKline Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table GlaxoSmithKline Live Attenuated Vaccines Main Business and Markets Served
Table Merck Live Attenuated Vaccines Production Sites and Area Served
Table Merck Live Attenuated Vaccines Product Introduction, Application and Specification
Table Merck Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Merck Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Merck Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Merck Live Attenuated Vaccines Main Business and Markets Served
Table Pfizer Live Attenuated Vaccines Production Sites and Area Served
Table Pfizer Live Attenuated Vaccines Product Introduction, Application and Specification
Table Pfizer Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Pfizer Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Pfizer Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Pfizer Live Attenuated Vaccines Main Business and Markets Served
Table Astellas Pharma Live Attenuated Vaccines Production Sites and Area Served
Table Astellas Pharma Live Attenuated Vaccines Product Introduction, Application and Specification
Table Astellas Pharma Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Astellas Pharma Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Astellas Pharma Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Astellas Pharma Live Attenuated Vaccines Main Business and Markets Served
Table Johnson & Johnson Live Attenuated Vaccines Production Sites and Area Served
Table Johnson & Johnson Live Attenuated Vaccines Product Introduction, Application and Specification
Table Johnson & Johnson Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Johnson & Johnson Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Johnson & Johnson Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Johnson & Johnson Live Attenuated Vaccines Main Business and Markets Served
Table CSL Live Attenuated Vaccines Production Sites and Area Served
Table CSL Live Attenuated Vaccines Product Introduction, Application and Specification
Table CSL Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table CSL Live Attenuated Vaccines Production Market Share (2014-2019)
Figure CSL Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table CSL Live Attenuated Vaccines Main Business and Markets Served
Table Sanofi Live Attenuated Vaccines Production Sites and Area Served
Table Sanofi Live Attenuated Vaccines Product Introduction, Application and Specification
Table Sanofi Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Sanofi Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Sanofi Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Sanofi Live Attenuated Vaccines Main Business and Markets Served
Table Serum Institute Of India Live Attenuated Vaccines Production Sites and Area Served
Table Serum Institute Of India Live Attenuated Vaccines Product Introduction, Application and Specification
Table Serum Institute Of India Live Attenuated Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Serum Institute Of India Live Attenuated Vaccines Production Growth Rate (2014-2019)
Table Serum Institute Of India Live Attenuated Vaccines Production Market Share (2014-2019)
Figure Serum Institute Of India Live Attenuated Vaccines Revenue Market Share (2014-2019)
Table Serum Institute Of India Live Attenuated Vaccines Main Business and Markets Served
Figure Global Live Attenuated Vaccines Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Live Attenuated Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Live Attenuated Vaccines Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Live Attenuated Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Live Attenuated Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Live Attenuated Vaccines by Type (2019-2025)
Table Global Consumption (K Units) of Live Attenuated Vaccines by Application (2019-2025)
Table Live Attenuated Vaccines Distributors List
Table Live Attenuated Vaccines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *